51 related articles for article (PubMed ID: 28244465)
21. 5-Aminolevulinic acid-guided resection improves the overall survival of patients with glioblastoma-a comparative cohort study of 343 patients.
Baig Mirza A; Christodoulides I; Lavrador JP; Giamouriadis A; Vastani A; Boardman T; Ahmed R; Norman I; Murphy C; Devi S; Vergani F; Gullan R; Bhangoo R; Ashkan K
Neurooncol Adv; 2021; 3(1):vdab047. PubMed ID: 34131646
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Nomograms for Primary High-Grade Glioma Patients in Adult: A Retrospective Study Based on the SEER Database.
Yang Y; Yao M; Long S; Xu C; Li L; Li Y; Li G
Biomed Res Int; 2020; 2020():1346340. PubMed ID: 32775408
[TBL] [Abstract][Full Text] [Related]
23. A Novel Comprehensive Clinical Stratification Model to Refine Prognosis of Glioblastoma Patients Undergoing Surgical Resection.
Ius T; Pignotti F; Della Pepa GM; La Rocca G; Somma T; Isola M; Battistella C; Gaudino S; Polano M; Dal Bo M; Bagatto D; Pegolo E; Chiesa S; Arcicasa M; Olivi A; Skrap M; Sabatino G
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32046132
[TBL] [Abstract][Full Text] [Related]
24. miR-137 acts as a tumor suppressor via inhibiting CXCL12 in human glioblastoma.
Li D; Shan W; Fang Y; Wang P; Li J
Oncotarget; 2017 Nov; 8(60):101262-101270. PubMed ID: 29254162
[TBL] [Abstract][Full Text] [Related]
25. MiR-145 inhibits the epithelial-to-mesenchymal transition via targeting ADAM19 in human glioblastoma.
Wang X; Wang E; Cao J; Xiong F; Yang Y; Liu H
Oncotarget; 2017 Nov; 8(54):92545-92554. PubMed ID: 29190936
[TBL] [Abstract][Full Text] [Related]
26. A Survival Score Based on Symptoms and Performance Status for Patients with High-grade Gliomas Receiving Radiochemotherapy.
Phuong PC; Nam LV; Schild SE; Rades D; Khoa MT
In Vivo; 2017; 31(4):689-693. PubMed ID: 28652440
[TBL] [Abstract][Full Text] [Related]
27. Cerebellar glioblastoma: a retrospective review of 21 patients at a single institution.
Tsung AJ; Prabhu SS; Lei X; Chern JJ; Benjamin Bekele N; Shonka NA
J Neurooncol; 2011 Dec; 105(3):555-62. PubMed ID: 21643841
[TBL] [Abstract][Full Text] [Related]
28. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
[TBL] [Abstract][Full Text] [Related]
30. Primary Spinal Cord Glioblastoma Multiforme: A Retrospective Study of Patients at a Single Institution.
Cheng X; Lou S; Huang S; Chen H; Liu J
World Neurosurg; 2017 Oct; 106():113-119. PubMed ID: 28377242
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in patients with glioblastoma multiforme: focus on the pathologic variants.
Alimohammadi E; Bagheri SR; Sadeghsalehi A; Rizevandi P; Rezaie Z; Abdi A
Acta Neurol Belg; 2020 Dec; 120(6):1341-1350. PubMed ID: 31222512
[TBL] [Abstract][Full Text] [Related]
32. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.
Piroth MD; Gagel B; Pinkawa M; Stanzel S; Asadpour B; Eble MJ
Strahlenther Onkol; 2007 Dec; 183(12):695-702. PubMed ID: 18040615
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors effective on survival of patients with glioblastoma: Anadolu Medical Center experience.
Guden M; Ayata HB; Ceylan C; Kilic A; Engin K
Indian J Cancer; 2016; 53(3):382-386. PubMed ID: 28244465
[TBL] [Abstract][Full Text] [Related]
34. Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.
Hollon T; Nguyen V; Smith BW; Lewis S; Junck L; Orringer DA
J Neurosurg; 2016 Aug; 125(2):410-8. PubMed ID: 26745489
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
